All In MedTech

Device Trial Radar · NCT04817267

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Last checked: Nov 19, 2026Latest source record: May 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

8

Actual

Start

Mar 11, 2022

Primary completion

Jan 1, 2023

Study completion May 1, 2024

Sponsor

Lead sponsor
Johns Hopkins UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Pear Therapeutics, Inc.
First posted
Mar 26, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.

Conditions

  • Opioid-use Disorder

Interventions

  • reSET-O appDevice

    The reSET-O app, a prescription digital therapeutic, provides cognitive behavioral therapy for opioid use disorder. The app provides psychoeducation related to opioid use, coping skills, and skills to avoid relapse.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of approached patients who are eligible for and interested in participationTime frame: 3 months
  2. Acceptability as assessed by the Treatment Acceptability QuestionnaireTime frame: 3 months
  3. Acceptability as assessed by the System Usability ScaleTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Bayivew Emergency Department

    Baltimore, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.